In COPD, which non-pharmacologic intervention is recommended to improve symptoms and quality of life?

In COPD, which non-pharmacologic intervention is recommended to improve symptoms and quality of life?

• A. Antibiotics
• B. Pulmonary rehabilitation
• C. Long-term oxygen therapy
• D. Antihistamines

Answer: (B)

Pulmonary rehabilitation is the nonpharmacologic intervention with the strongest and most consistent benefit for COPD symptoms and overall quality of life. It’s a structured program that combines supervised exercise training, education on breathing techniques and energy conservation, and strategies for managing the disease, including nutrition and inhaler use. Regular participation improves dyspnea, increases exercise tolerance, enhances daily functioning, and can reduce hospitalizations, making it a cornerstone of COPD care for patients who remain symptomatic or have limited activity. Antibiotics are used to treat infections or exacerations, not as a routine nonpharmacologic plan to improve baseline symptoms. Long-term oxygen therapy can extend survival and improve quality of life, but only in patients with chronic hypoxemia, so it isn’t a universal nonpharmacologic intervention for all COPD patients. Antihistamines target allergic symptoms and do not address COPD pathology or typical symptoms.

Pulmonary rehabilitation is the nonpharmacologic intervention with the strongest and most consistent benefit for COPD symptoms and overall quality of life. It’s a structured program that combines supervised exercise training, education on breathing techniques and energy conservation, and strategies for managing the disease, including nutrition and inhaler use. Regular participation improves dyspnea, increases exercise tolerance, enhances daily functioning, and can reduce hospitalizations, making it a cornerstone of COPD care for patients who remain symptomatic or have limited activity.

Antibiotics are used to treat infections or exacerations, not as a routine nonpharmacologic plan to improve baseline symptoms. Long-term oxygen therapy can extend survival and improve quality of life, but only in patients with chronic hypoxemia, so it isn’t a universal nonpharmacologic intervention for all COPD patients. Antihistamines target allergic symptoms and do not address COPD pathology or typical symptoms.